InvestWiser

Apotea

APOTEANasdaq StockholmHealthcareMarket value 10.5 bn SEK
101.30SEK +0.1%
last day · Price as of 18 November 2026

The answer first

Does Apotea beat the market?

Apotea has moved roughly in line with the market over the last year.

Apotea+18.4%Stockholm (OMXSGI)+17.6%
  • The ranking · Quality, value and trend combined

    Better than 86% of Nordic stocks

    • Quality92
    • Value25
    • Trend89

    No. 17 of 195 in healthcare

  • Expectations in the price

    High expectations

    For the share to return about 9% a year from today's price, the cash Apotea keeps must grow about 25% a year for 10 years.

Max for seven days

Follow Apotea with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Apotea

From today, at a price of 101.30 SEK. Write why you follow Apotea, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Apotea

Your first answer is free, no account needed.

Do you own Apotea, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Apotea and a few more. Free, no card.

Past year against the exchange and Super Stock
Apotea+18.4%Stockholm (OMXSGI)+17.6%Super Stock+44.6%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Apotea has risen 18.4% over the past year, including dividends.
  • Overall, Apotea ranks better than 86% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 54.1%. The price is 15.7% below its peak now.

What do analysts think of Apotea?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

86

Quality, value and trend together. Better than 86% of Nordic stocks.

No. 17 of 195 in healthcare

Quality92
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 27 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.32
  • Asset turnoverSales divided by everything the company owns3.65
  • Return on equityProfit divided by equity+25.1%
  • Cash conversionOperating cash flow divided by profit0.58

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value25
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 82 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity10.1
  • P/SPrice divided by sales1.3
  • P/EPrice divided by earnings40.2
  • P/CFPrice divided by operating cash flow69.1

The ranking is built on P/E, P/B and P/S.

Trend89
The share price · Technical: the price trend

High Tailwind in the share price: it has risen more than most over the last year.

No. 28 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+36.6%
  • 6 months+31.4%
  • 9 months+76.3%
  • 12 months+18.4%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
+13.4%
3 years, per year
–
5 years, per year
–
Year to date
+10.7%
Largest fall, 3 years
−54.1%
From a peak to the bottom
From the peak now
−15.7%
How far the price is from the peak
Volatility, 1 year
38.5%
How much the price swings over a year
Beta, 1 year
0.38
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Apotea

21 funds we follow own Apotea. The share is how much of the fund the stock makes up.

  • Norway1
  • Sweden20
  • 1 ETF

From the funds' latest known holdings.

About Apotea

Apotea is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 700 employees.

Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, baby, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and drink, mouth and teeth, premium, trip, sex and lust, stop smoking, makeup, sun protection, wounds and injuries, sleep and sleep problems, training, weight control, vitamins and minerals, charity, and eyes and ears.

See the full analysis of Apotea.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market